Insmed (INSM) Depreciation & Amortization (CF) (2010 - 2026)

Insmed's Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) rose 55.82% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $11.5 million (up 81.91% YoY), while the FY2025 annual figure was $10.4 million, up 73.33% from the prior year.
• Depreciation & Amortization (CF) was $2.9 million for Q1 2026 at Insmed, down from $3.6 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $3.6 million in Q4 2025 to a low of $851000.0 in Q3 2022.
• Historically, Depreciation & Amortization (CF) has averaged $1.8 million across 5 years, with a median of $1.5 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) slumped 61.97% in 2022, then surged 135.66% in 2025.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $2.2 million in 2022, then plunged by 32.43% to $1.5 million in 2023, then grew by 2.85% to $1.5 million in 2024, then soared by 135.66% to $3.6 million in 2025, then dropped by 17.93% to $2.9 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $2.9 million (Q1 2026), $3.6 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.